Trial NCT01193881

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2010-01975
Secondary IDs: 2009-0769 8508 N01CM00039 N01CM62202 NCI-2010-01975 P30CA016672 U01CA062461

Last trial update was posted on 2015-09-29

MeSH Interventions

2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide Erlotinib Hydrochloride Gamma Secretase Inhibitors and Modulators

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Recurrent Non-Small Cell Lung Carcinoma Stage IV Non-Small Cell Lung Cancer

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID